Disease-free survival 5 years [clinicaltrials_resource:159c478c65683867c37cafc7a850aa67]
To evaluate the disease-free survival (DFS) in the two randomized arms after therapy with LC vs. EC in chemo-naive Her2-patients with stage I or II breast cancer
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Disease-free survival 5 years [clinicaltrials_resource:159c478c65683867c37cafc7a850aa67]
To evaluate the disease-free survival (DFS) in the two randomized arms after therapy with LC vs. EC in chemo-naive Her2-patients with stage I or II breast cancer
Bio2RDF identifier
159c478c65683867c37cafc7a850aa67
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:159c478c65683867c37cafc7a850aa67
measure [clinicaltrials_vocabulary:measure]
Disease-free survival
time frame [clinicaltrials_vocabulary:time-frame]
description
To evaluate the disease-free s ...... th stage I or II breast cancer
identifier
clinicaltrials_resource:159c478c65683867c37cafc7a850aa67
title
Disease-free survival 5 years
@en
type
label
Disease-free survival 5 years [clinicaltrials_resource:159c478c65683867c37cafc7a850aa67]
@en